Myeloma Care:
A Distinctive Program Aimed at a Cure
The Myeloma Program at Holden Comprehensive Cancer Center is known for its tandem transplant protocol, a treatment approach offered at very few medical centers around the country. Research demonstrates that the median survival rate with this treatment process is 10 years or more and that 80% of newly diagnosed myeloma patients will achieve complete remission. No other treatment method for multiple myeloma has proven to be as effective in research studies.
Guido Tricot, MD, PhD, who directs the program, has been specializing in multiple myeloma for more than two decades.
“When I started treating myeloma, the median survival for patients was about 2 and a half years," Dr. Tricot says. "Today, we have aggressive and effective therapies available, like our tandem transplant protocol, that have increased the median survival to more than 10 years. My goal is to keep patients alive with the best quality of life possible until we find a cure.”
Dr. Tricot also has extensive knowledge in treating and evaluating patients with myeloma-related conditions, like amyloidosis, MGUS, plasmacytomas, Waldenström's disease, and Castleman’s disease.
Starting Your Care with Us
We invite you to contact one of our patient care coordinators--Julie Aschenbrenner or Beth Kaufman--to begin planning for your care. They can be reached at 319-356-3337 or by e-mail at: abmt@uiowa.edu
Send Us Your Questions
Please use our on-line form to send us questions about our treatment philosophy, our research, or the treatment process.
If You Are Transferring Your Care
Please download the consent form to have your medical records released to University of Iowa Hospitals and Clinics. When you have completed the form please mail it to:
Adult Blood and Marrow Transplantation Program
University of Iowa Hospitals and Clinics
Department of Internal Medicine
C332 General Hospital
200 Hawkins Drive
Iowa City, IA 52242